Edwards Lifesciences (EW) Other Non-Current Assets (2009 - 2026)

Edwards Lifesciences has reported Other Non-Current Assets for 18 years, with the latest figure at $738.9 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 0.51% year-over-year to $738.9 million; the trailing twelve-month figure through Mar 2026 stood at $738.9 million (down 0.51% YoY), and the FY2025 full-year result was $730.2 million, up 2624.63% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $738.9 million, up from $730.2 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $767.6 million in Q1 2024, with the low at $26.8 million in Q4 2024.
• Average Other Non-Current Assets over 5 years is $424.6 million, with a median of $316.5 million recorded in 2022.
• Peak annual rise in Other Non-Current Assets reached 2624.63% in 2025, while the deepest fall reached 94.94% in 2025.
• Tracing EW's Other Non-Current Assets over 5 years: stood at $299.1 million in 2022, then advanced by 4.01% to $311.1 million in 2023, then tumbled by 91.39% to $26.8 million in 2024, then jumped by 2624.63% to $730.2 million in 2025, then gained by 1.19% to $738.9 million in 2026.
• The last three Other Non-Current Assets figures came in at $738.9 million (Q1 2026), $730.2 million (Q4 2025), and $34.6 million (Q3 2025), per Business Quant data.

Peer Comparison